يعرض 1 - 10 نتائج من 61 نتيجة بحث عن '"Higano C. S."', وقت الاستعلام: 1.11s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Francini, E., Montagnani, F., Nuzzo, P. V., Gonzalez-Velez, M., Alimohamed, N. S., Rosellini, P., Moreno-Candilejo, I., Cigliola, A., Rubio-Perez, J., Crivelli, F., Shaw, G. K., Zhang, L., Petrioli, R., Bengala, C., Francini, G., Garcia-Foncillas, J., Sweeney, C. J., Higano, C. S., Bryce, A. H., Harshman, L. C., Lee-Ying, R., Heng, D. Y. C.

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34292336; info:eu-repo/semantics/altIdentifier/wos/WOS:000676010700001; volume:4; issue:7; firstpage:1; lastpage:13; numberofpages:13; journal:JAMA NETWORK OPEN; http://hdl.handle.net/11365/1189295Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85111167193; https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782169Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299314Test/

  2. 2
    دورية أكاديمية

    المساهمون: Morris M.J., Loriot Y., Sweeney C.J., Fizazi K., Ryan C.J., Shevrin D.H., Antonarakis E.S., Pandit-Taskar N., Deandreis D., Jacene H.A., Vesselle H., Petrenciuc O., Lu C., Carrasquillo J.A., Higano C.S.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31082669; info:eu-repo/semantics/altIdentifier/wos/WOS:000469879000012; volume:114; firstpage:107; lastpage:116; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/2318/1717937Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85065249888; http://www.journals.elsevier.com/european-journal-of-cancerTest/

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Bryce , A H , Alumkal , J J , Armstrong , A , Higano , C S , Iversen , P , Sternberg , C N , Rathkopf , D , Loriot , Y , de Bono , J , Tombal , B , Abhyankar , S , Lin , P , Krivoshik , A , Phung , D & Beer , T M 2017 , ' Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer : post hoc analysis of PREVAIL ' , Prostate Cancer and Prostatic Diseases , vol. 20 , pp. 221-227 . https://doi.org/10.1038/pcan.2016.71Test

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية

    المساهمون: Dana-Farber Cancer Institute, Boston, MA, United States. University of Washington, United States. Institute of Cancer Research, Sutton, United Kingdom. Christie NHS Foundation Trust and the University of Manchester, Manchester, United Kingdom. Memorial Sloan Kettering Cancer Center, New York, New York, United States. University of Wisconsin Carbone Cancer Center, Madison, Wi, United States. Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain. University College London Cancer Institute, London, United Kingdom. Karmanos Cancer Center, Detroit, MI, United States. Cancer Research UK Cambridge Centre, Cambridge, United Kingdom. Hospital Clinic Barcelona / IDIBAPs, Barcelona, Cataluña, Spain. Spanish National Cancer Research Centre, Madrid, Madrid, Spain. AstraZeneca (United Kingdom), Cambridge, United Kingdom. AstraZeneca (Australia), Cambridge, United Kingdom. AstraZeneca (United States), Waltham, United States. AstraZeneca (United Kingdom), Boston, MA, United Kingdom. Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. Princess Margaret Hospital, Toronto, ON, Canada.

    العلاقة: https://dx.doi.org/10.1158/1078-0432.Ccr-21-3087Test; Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, et al. A phase I study investigating AZD8186, a potent and selective inhibitor of PI3Kβ/δ, in patients with advanced solid tumors. Clin Cancer Res. 2022.; http://hdl.handle.net/10541/625120Test; Clinical Cancer Research

  6. 6
    مؤتمر

    المساهمون: Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA

    العلاقة: Higano CS, Harshman LC, Dizdarevic S, Logue JP, Richardson T, George S, et al. Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) plus subsequent taxane therapy. Journal of Clinical Oncology. 2020;38(15); http://hdl.handle.net/10541/623389Test; Journal of Clinical Oncology

  7. 7
    دورية أكاديمية

    المساهمون: de Bono J.S., Mehra N., Scagliotti G.V., Castro E., Dorff T., Stirling A., Stenzl A., Fleming M.T., Higano C.S., Saad F., Buttigliero C., van Oort I.M., Laird A.D., Mata M., Chen H.-C., Healy C.G., Czibere A., Fizazi K.

    العلاقة: volume:22; issue:9; firstpage:1250; lastpage:1264; numberofpages:15; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/2318/1799984Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85112511545

  8. 8
    دورية أكاديمية

    المساهمون: Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

    العلاقة: https://dx.doi.org/10.1161/circulationaha.121.056810Test; Lopes RD, Higano CS, Slovin SF, Nelson AJ, Bigelow R, Sørensen PS, et al. Cardiovascular Safety of Degarelix versus Leuprolide in Patients with Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial. Circulation. 2021 Aug 30.; http://hdl.handle.net/10541/624586Test; Circulation

  9. 9
    دورية أكاديمية

    المصدر: PREVAIL Investigators , Beer , T M , Armstrong , A J , Rathkopf , D E , Loriot , Y , Sternberg , C N , Higano , C S , Iversen , P , Bhattacharya , S , Carles , J , Chowdhury , S , Davis , I D , de Bono , J S , Evans , C P , Fizazi , K , Joshua , A M , Kim , C-S , Kimura , G , Mainwaring , P , Mansbach , H , Miller , K , Noonberg , S B , Perabo ....

    وصف الملف: application/pdf

  10. 10
    دورية أكاديمية